How to Get Testosterone Cypionate in North Dakota

North Dakota Allows Telehealth Testosterone Prescriptions

Providers licensed in North Dakota can prescribe testosterone cypionate through telehealth platforms, and this route has become the most common first step for men seeking TRT in the state. The North Dakota Board of Medicine recognizes synchronous audio-video consultations as sufficient to establish a provider-patient relationship for controlled substance prescribing, provided the encounter meets the same standard of care as an in-person visit.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic androgen deficiency confirmed by reliably low morning serum testosterone concentrations on at least two occasions (1). A telehealth visit satisfies this requirement when the clinician reviews qualifying lab results, evaluates symptoms (fatigue, reduced libido, depressed mood, loss of lean mass), and documents a treatment rationale in the medical record.

North Dakota's sparse population density makes telehealth especially practical. Bismarck, Fargo, Grand Forks, and Minot have endocrinology and urology practices, but men in rural counties may live 90 or more miles from the nearest specialist. A 2022 analysis in Telemedicine and e-Health found that telehealth-initiated testosterone therapy showed comparable adherence rates and clinical outcomes to in-person-initiated therapy over 12 months (2).

After the telehealth consultation, the prescriber sends an electronic prescription to the patient's pharmacy of choice. Because testosterone cypionate is a Schedule III controlled substance under federal and North Dakota law, the prescription must include the prescriber's DEA number.

Labs Required Before Starting Testosterone Cypionate

You cannot obtain a legitimate testosterone cypionate prescription without bloodwork. Two separate morning total testosterone levels below 300 ng/dL are the diagnostic threshold used by most clinical guidelines, including the American Urological Association's 2018 consensus statement (3).

Blood draws should occur between 7:00 AM and 10:00 AM, when testosterone peaks in its circadian rhythm. Quest Diagnostics and Labcorp both operate draw sites across North Dakota, including locations in Fargo, Bismarck, and Grand Forks. Many telehealth TRT platforms will order labs at a partner facility or accept results from your primary care provider within the past 90 days.

The baseline lab panel typically includes:

• Total testosterone (LC-MS/MS preferred)
• Free testosterone (calculated or equilibrium dialysis)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
• Complete blood count with hematocrit
• Comprehensive metabolic panel
• Lipid panel
• Prostate-specific antigen (PSA) for men over 40
• Estradiol (sensitive assay)

The Endocrine Society guideline specifically recommends against starting testosterone therapy in men with a hematocrit above 50%, untreated severe obstructive sleep apnea, uncontrolled heart failure, or a PSA above 4 ng/mL without urological evaluation (1). These are hard contraindications, not suggestions.

Follow-up labs at 3 months, 6 months, and then every 6 to 12 months are standard once therapy begins. Hematocrit monitoring is non-negotiable. The T-Trials (N=790) found that testosterone treatment in older men increased hemoglobin by a mean of 1.0 g/dL compared to placebo (4), and unchecked polycythemia raises the risk of thromboembolic events.

Who Can Prescribe Testosterone Cypionate in North Dakota

Three categories of providers hold prescriptive authority for Schedule III controlled substances in North Dakota. MDs and DOs have unrestricted prescribing rights. Nurse practitioners with full practice authority (granted after a supervised transition period under North Dakota Century Code 43-12.1) can prescribe independently. Physician assistants prescribe under a collaborative agreement with a supervising physician, which must specifically authorize controlled substance prescribing.

The practical difference for patients is minimal. What matters is whether the prescriber has a valid DEA registration and is licensed to practice in North Dakota. Telehealth platforms that operate nationally typically credential their providers in each state where they accept patients, so an NP based in Minnesota who holds a North Dakota license can legally prescribe testosterone cypionate to a patient in Williston.

Dr. Bradley Anawalt, an endocrinologist at the University of Washington and co-author of the Endocrine Society guideline, has stated: "The key to safe testosterone prescribing is not the letters after the clinician's name but whether they follow evidence-based diagnostic criteria and monitoring protocols" (1). This applies whether you see an endocrinologist in Fargo or a family medicine NP via video call.

Testosterone Cypionate Dosing and Administration

The FDA-approved prescribing information for testosterone cypionate lists a dose range of 50 to 400 mg intramuscularly every two to four weeks for the treatment of male hypogonadism (5). In current clinical practice, most prescribers use 100 to 200 mg per week or divided into twice-weekly injections to reduce peak-trough fluctuations.

Subcutaneous injection has gained acceptance as an alternative to intramuscular delivery. A 2017 study published in The Journal of Clinical Endocrinology & Metabolism (N=232) demonstrated that subcutaneous testosterone cypionate at weekly doses of 50 to 100 mg achieved equivalent serum testosterone levels to intramuscular injections, with 95% of patients reaching the eugonadal range of 400 to 700 ng/dL (6). Subcutaneous injections use a shorter needle (27 to 29 gauge, 0.5 inch) and are easier for self-administration at home.

Your prescriber in North Dakota will specify the route, dose, and frequency. Most men self-inject at home after an initial training session (which can occur over video). Testosterone cypionate is dissolved in cottonseed oil in the branded product (Depo-Testosterone) and in various carrier oils in compounded formulations.

Dose adjustments are driven by follow-up lab values. The target trough total testosterone on therapy is 400 to 700 ng/dL, measured 24 hours before the next injection for weekly protocols. If trough levels are below 400 ng/dL, the dose is increased. If hematocrit rises above 54%, the dose is reduced or therapy is paused.

503A Compounding Pharmacies in North Dakota

North Dakota permits state-licensed 503A compounding pharmacies to prepare and dispense testosterone cypionate with a valid patient-specific prescription. This is important because compounded testosterone cypionate typically costs 40 to 60% less than the branded Depo-Testosterone product. A 10 mL vial of compounded testosterone cypionate 200 mg/mL generally runs $30, $80 out of pocket, compared to $80, $150 or more for the commercial product at retail pharmacies.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies must prepare each prescription for an individually identified patient, use USP-grade ingredients, and comply with state Board of Pharmacy oversight. The North Dakota Board of Pharmacy requires 503A facilities to hold an active state license and comply with USP <797> and USP <800> sterile compounding standards (7).

Several 503A pharmacies licensed in North Dakota ship directly to patients within the state. Your prescriber can electronically transmit the prescription to any qualifying pharmacy. If you are using a telehealth platform, it will typically have a preferred compounding pharmacy partner already vetted for quality and turnaround time.

One point of caution: testosterone cypionate is a Schedule III controlled substance, so compounding pharmacies must also hold a DEA registration. Verify this before filling.

North Dakota Medicaid Does Not Cover Testosterone Cypionate

North Dakota Medicaid does not include testosterone cypionate on its preferred drug list for the treatment of male hypogonadism. This means Medicaid beneficiaries in the state will need to pay out of pocket or explore alternative coverage pathways.

Private insurance coverage varies by plan. Most commercial insurers, including Blue Cross Blue Shield of North Dakota and Sanford Health Plan, cover testosterone cypionate with prior authorization when the diagnosis of hypogonadism is supported by two qualifying lab values and documented symptoms. The prior authorization process typically requires:

• ICD-10 diagnosis code E29.1 (testicular hypofunction)
• Two morning total testosterone levels below 300 ng/dL
• Documentation that symptoms are present (fatigue, sexual dysfunction, mood changes)
• Confirmation that the patient does not have contraindications listed in the prescribing information

A 2020 study in Urology surveyed 129 insurance formularies and found that 78% covered injectable testosterone cypionate as a Tier 2 or Tier 3 generic, with prior authorization required by 61% of plans (8). If your insurer denies coverage, your prescriber can submit a peer-to-peer review or you can fill at a 503A compounding pharmacy for a lower cash price.

For men without insurance, GoodRx and similar discount programs list generic testosterone cypionate 200 mg/mL (10 mL vial) at $40, $90 at major chain pharmacies in North Dakota, including Walgreens in Fargo and CVS locations across the state.

Transferring a Testosterone Cypionate Prescription to North Dakota

If you are relocating to North Dakota with an existing testosterone cypionate prescription from another state, the process is straightforward but has one regulatory step. Your current prescriber must be licensed in North Dakota or you must establish care with a new North Dakota-licensed provider.

A pharmacy-to-pharmacy transfer of a Schedule III prescription is permitted under both federal and North Dakota law for the remaining refills on an active prescription. You can call a North Dakota pharmacy and request the transfer. The receiving pharmacist will contact your out-of-state pharmacy directly. This applies to both retail and compounding pharmacies.

If your prescription has no remaining refills, or if your out-of-state prescriber prefers not to authorize a transfer, you will need a new prescription from a North Dakota-licensed provider. A telehealth consultation with recent lab work (within 90 days) can accomplish this in a single visit.

The AUA 2018 guideline notes that continuity of monitoring is as important as continuity of the prescription itself. When transitioning care, bring your full lab history, including baseline pre-treatment values, so your new provider can assess trajectory rather than starting from scratch (3).

Timeline from Consultation to First Injection

Most men in North Dakota receive their first testosterone cypionate injection within 7 to 14 days of their initial consultation. The timeline breaks down as follows:

• Day 1 to 2: Schedule telehealth visit or in-person appointment
• Day 2 to 5: Complete lab work at a local draw site (results in 24 to 72 hours)
• Day 5 to 7: Follow-up visit to review labs, confirm diagnosis, receive prescription
• Day 7 to 14: Pharmacy fills and ships (or you pick up locally)

The main variable is lab turnaround time. Quest and Labcorp results are typically available within 48 hours. If you have qualifying labs from the past 90 days, your prescriber may review those at the initial visit and write the prescription the same day, compressing the timeline to 3 to 7 days.

Compounding pharmacies that ship direct-to-patient within North Dakota generally deliver in 3 to 5 business days. Retail pharmacies with the product in stock can fill same-day.